SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 20.39 |
| Enterprise Value ($M) | 15.21 |
| Book Value ($M) | 59.49 |
| Book Value / Share | 8.93 |
| Price / Book | 0.34 |
| NCAV ($M) | 47.12 |
| NCAV / Share | 7.07 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.28 |
| Return on Assets (ROA) | 0.15 |
| Return on Equity (ROE) | 0.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.23 |
| Current Ratio | 8.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 66.17 |
| Assets | 78.54 |
| Liabilities | 19.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 4.90 | -9.69 | |
| 13G/A | Vanguard Group Inc | 5.85 | ||
| 13D/A | Anson Funds Management LP | 16.40 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,472 | 16,836 | 26.56 | |
| 2,659 | 2,872 | 92.58 | |
| 6,045 | 2,355 | 256.69 | |
| 495 | 535 | 92.52 | |
| 4,128 | 2,033 | 203.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LTRN – Lantern Pharma Inc. | MBIO – Mustang Bio, Inc. |
| MBRX – Moleculin Biotech, Inc. | MIRA – MIRA Pharmaceuticals, Inc. |
| MLTX – MoonLake Immunotherapeutics |